Country report: Turkey
Report description
Turkey has always been a bridge between Europe and Asia with untapped potential in a variety of industries. With a population of about 75 million and GDP growth of 7.8 per cent based on IMF's 2010 forecast, it represents a unique opportunity for the pharmaceutical industry.
Please note
These downloads are single copies for your personal use only as specified in our site terms and conditions.
If you are interested in buying bulk copies in either digital or print formats, or you would like to find out how PMLiVE and PMGroup could fulfil your business needs, please see our corporate site, send us a message – or call our sales team on +44 (0)1372 414200.